JP Stock MarketDetailed Quotes

4875 MediciNova

Watchlist
  • 312
  • +17+5.76%
20min DelayMarket Closed Nov 22 15:30 JST
15.30BMarket Cap-13014P/E (Static)

MediciNova Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-17.96%-2.81M
-21.74%-3.87M
42.45%-7.43M
87.55%-499.06K
49.58%-1.37M
2.97%-2.38M
14.78%-3.18M
-37.63%-12.91M
-10.11%-4.01M
9.80%-2.72M
Net income from continuing operations
8.48%-2.63M
5.59%-2.75M
39.08%-8.57M
31.40%-2.06M
80.20%-723.11K
28.72%-2.87M
13.85%-2.92M
-38.83%-14.07M
-44.08%-3M
-2.04%-3.65M
Operating gains losses
----
----
266.91%449.38K
--346.49K
--371
--0
--102.51K
42,723.43%122.48K
----
----
Depreciation and amortization
7.51%5.37K
30.33%5.35K
14.62%20.3K
26.81%5.49K
27.90%5.7K
11.30%5K
-7.32%4.11K
-32.28%17.71K
-32.05%4.33K
-37.79%4.46K
Remuneration paid in stock
-36.31%207.46K
-46.58%215.43K
10.61%710.71K
-284.51%-237.41K
38.44%219.14K
18.65%325.71K
397.53%403.26K
-62.59%642.52K
117.00%128.67K
-72.66%158.3K
Other non cashItems
-26.30%36.2K
-0.26%49.39K
-473.04%-151.89K
-236.61%-298.09K
70.60%47.56K
-12.61%49.12K
9.61%49.52K
-81.21%40.72K
-265.97%-88.56K
-47.15%27.88K
Change In working capital
-496.20%-431.76K
-68.91%-1.38M
-66.48%111.99K
248.71%1.74M
-224.25%-921.22K
-91.20%108.98K
-73.35%-819.31K
127.66%334.1K
-36.51%-1.17M
1,084.29%741.4K
-Change in prepaid assets
-409.15%-395.75K
-77.46%-551.75K
90.98%287.63K
57.12%315.11K
82.07%155.42K
-69.44%128.01K
43.90%-310.91K
199.30%150.61K
-64.24%200.55K
220.45%85.36K
-Change in payables and accrued expense
-98.33%507
-70.14%-781.35K
-94.15%19.24K
135.82%476.91K
-104.09%-28.8K
-96.40%30.37K
-512.43%-459.25K
132.05%329.01K
1.90%-1.33M
1,404.57%704.14K
-Change in other current liabilities
26.10%-36.51K
-3.37%-50.81K
-33.92%-194.88K
-16.01%-48.48K
0.56%-47.84K
-91.54%-49.41K
-64.80%-49.15K
37.21%-145.52K
33.30%-41.79K
6.14%-48.11K
Cash from discontinued investing activities
Operating cash flow
-17.96%-2.81M
-21.74%-3.87M
42.45%-7.43M
87.55%-499.06K
49.58%-1.37M
2.97%-2.38M
14.78%-3.18M
-37.63%-12.91M
-10.11%-4.01M
9.80%-2.72M
Investing cash flow
Cash flow from continuing investing activities
95.20%-891
0
199.76%39.91M
100.00%22
99.97%-2.74K
-18.58K
39.93M
-139,135.03%-40.01M
-30.01M
-340,267.60%-10M
Net PPE purchase and sale
----
----
-325.13%-21.3K
100.44%22
---2.74K
----
----
82.56%-5.01K
---5.01K
--0
Net investment purchase and sale
--0
--0
199.82%39.93M
--0
--0
--0
--39.93M
---40M
---30M
---10M
Cash from discontinued investing activities
Investing cash flow
95.20%-891
--0
199.76%39.91M
100.00%22
99.97%-2.74K
---18.58K
--39.93M
-139,135.03%-40.01M
---30.01M
-340,267.60%-10M
Financing cash flow
Cash flow from continuing financing activities
0
0
-99.96%7.92K
0
0
Net common stock issuance
----
----
--0
--0
----
----
----
-99.96%7.92K
--0
--0
Cash from discontinued financing activities
Financing cash flow
----
----
--0
--0
----
----
----
-99.96%7.92K
--0
--0
Net cash flow
Beginning cash position
-14.70%47.14M
175.59%51M
-74.09%18.51M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
-74.09%18.51M
18.98%71.43M
-30.01%52.51M
-16.14%65.23M
Current changes in cash
-17.08%-2.81M
-110.53%-3.87M
161.38%32.48M
98.53%-499.04K
89.20%-1.37M
1.90%-2.4M
1,085.72%36.75M
-565.43%-52.91M
-844.71%-34.01M
-359.39%-12.72M
Effect of exchange rate changes
-41.36%10.85K
234.58%7.61K
202.75%17.27K
-186.36%-8.88K
191.95%5.38K
232.71%18.5K
131.13%2.27K
-163.31%-16.81K
76.19%10.28K
-382.67%-5.85K
End cash Position
-16.15%44.34M
-14.70%47.14M
175.59%51M
175.59%51M
-1.90%51.51M
-18.94%52.88M
-18.37%55.26M
-74.09%18.51M
-74.09%18.51M
-30.01%52.51M
Free cash from
-17.08%-2.81M
-21.74%-3.87M
42.30%-7.45M
87.56%-499.04K
49.48%-1.37M
2.21%-2.4M
14.78%-3.18M
-37.26%-12.92M
-10.25%-4.01M
9.89%-2.72M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -17.96%-2.81M-21.74%-3.87M42.45%-7.43M87.55%-499.06K49.58%-1.37M2.97%-2.38M14.78%-3.18M-37.63%-12.91M-10.11%-4.01M9.80%-2.72M
Net income from continuing operations 8.48%-2.63M5.59%-2.75M39.08%-8.57M31.40%-2.06M80.20%-723.11K28.72%-2.87M13.85%-2.92M-38.83%-14.07M-44.08%-3M-2.04%-3.65M
Operating gains losses --------266.91%449.38K--346.49K--371--0--102.51K42,723.43%122.48K--------
Depreciation and amortization 7.51%5.37K30.33%5.35K14.62%20.3K26.81%5.49K27.90%5.7K11.30%5K-7.32%4.11K-32.28%17.71K-32.05%4.33K-37.79%4.46K
Remuneration paid in stock -36.31%207.46K-46.58%215.43K10.61%710.71K-284.51%-237.41K38.44%219.14K18.65%325.71K397.53%403.26K-62.59%642.52K117.00%128.67K-72.66%158.3K
Other non cashItems -26.30%36.2K-0.26%49.39K-473.04%-151.89K-236.61%-298.09K70.60%47.56K-12.61%49.12K9.61%49.52K-81.21%40.72K-265.97%-88.56K-47.15%27.88K
Change In working capital -496.20%-431.76K-68.91%-1.38M-66.48%111.99K248.71%1.74M-224.25%-921.22K-91.20%108.98K-73.35%-819.31K127.66%334.1K-36.51%-1.17M1,084.29%741.4K
-Change in prepaid assets -409.15%-395.75K-77.46%-551.75K90.98%287.63K57.12%315.11K82.07%155.42K-69.44%128.01K43.90%-310.91K199.30%150.61K-64.24%200.55K220.45%85.36K
-Change in payables and accrued expense -98.33%507-70.14%-781.35K-94.15%19.24K135.82%476.91K-104.09%-28.8K-96.40%30.37K-512.43%-459.25K132.05%329.01K1.90%-1.33M1,404.57%704.14K
-Change in other current liabilities 26.10%-36.51K-3.37%-50.81K-33.92%-194.88K-16.01%-48.48K0.56%-47.84K-91.54%-49.41K-64.80%-49.15K37.21%-145.52K33.30%-41.79K6.14%-48.11K
Cash from discontinued investing activities
Operating cash flow -17.96%-2.81M-21.74%-3.87M42.45%-7.43M87.55%-499.06K49.58%-1.37M2.97%-2.38M14.78%-3.18M-37.63%-12.91M-10.11%-4.01M9.80%-2.72M
Investing cash flow
Cash flow from continuing investing activities 95.20%-8910199.76%39.91M100.00%2299.97%-2.74K-18.58K39.93M-139,135.03%-40.01M-30.01M-340,267.60%-10M
Net PPE purchase and sale ---------325.13%-21.3K100.44%22---2.74K--------82.56%-5.01K---5.01K--0
Net investment purchase and sale --0--0199.82%39.93M--0--0--0--39.93M---40M---30M---10M
Cash from discontinued investing activities
Investing cash flow 95.20%-891--0199.76%39.91M100.00%2299.97%-2.74K---18.58K--39.93M-139,135.03%-40.01M---30.01M-340,267.60%-10M
Financing cash flow
Cash flow from continuing financing activities 00-99.96%7.92K00
Net common stock issuance ----------0--0-------------99.96%7.92K--0--0
Cash from discontinued financing activities
Financing cash flow ----------0--0-------------99.96%7.92K--0--0
Net cash flow
Beginning cash position -14.70%47.14M175.59%51M-74.09%18.51M-1.90%51.51M-18.94%52.88M-18.37%55.26M-74.09%18.51M18.98%71.43M-30.01%52.51M-16.14%65.23M
Current changes in cash -17.08%-2.81M-110.53%-3.87M161.38%32.48M98.53%-499.04K89.20%-1.37M1.90%-2.4M1,085.72%36.75M-565.43%-52.91M-844.71%-34.01M-359.39%-12.72M
Effect of exchange rate changes -41.36%10.85K234.58%7.61K202.75%17.27K-186.36%-8.88K191.95%5.38K232.71%18.5K131.13%2.27K-163.31%-16.81K76.19%10.28K-382.67%-5.85K
End cash Position -16.15%44.34M-14.70%47.14M175.59%51M175.59%51M-1.90%51.51M-18.94%52.88M-18.37%55.26M-74.09%18.51M-74.09%18.51M-30.01%52.51M
Free cash from -17.08%-2.81M-21.74%-3.87M42.30%-7.45M87.56%-499.04K49.48%-1.37M2.21%-2.4M14.78%-3.18M-37.26%-12.92M-10.25%-4.01M9.89%-2.72M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
JP
Overall
Symbol
Latest Price
% Chg

No Data